Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Trade Groups, Emord Rip FTC Interpretation Of POM Wonderful Ads

This article was originally published in The Tan Sheet

Executive Summary

An amici curiae brief filed in the POM Wonderful case by CHPA and CRN criticizes FTC for relying “on its own ‘expertise’ to determine the meaning of ambiguous advertisements.” A separate brief by attorney Jonathan Emord says FTC is creating unreasonable barriers for food product research.


Related Content

Court Upholds FTC Order Against POM, But Scrutinizes Clinical Trial Requirement
RCT Spells Requirement For Lipidryl, Shrinking Beauty Weight Loss Claims
Top Supplement Stories 2013: POM Saga, Spiked Products, GMPs
POM Wonderful Asks Court To Vacate “Draconian” FTC Order
POM Wonderful Misses Mark In Suit On FTC Claims Standard, Attorneys Say
FTC's Pending Claim Substantiation Changes Will Weigh On Small Firms


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts